These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9793002)

  • 1. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
    Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
    Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
    Drenth JP; Van Uum SH; Van Deuren M; Pesman GJ; Van der Ven-Jongekrijg J; Van der Meer JW
    J Appl Physiol (1985); 1995 Nov; 79(5):1497-503. PubMed ID: 8594005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production increased and tumour necrosis factor-alpha production decreased after a 5-km run?
    Gleeson M
    Eur J Clin Invest; 1998 Oct; 28(10):873-4. PubMed ID: 9793003
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Demacker PN; Bartelink AK; van Dalen R; Sauerwein RW; Gallati H; Vannice JL; van der Meer JW
    J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
    Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
    Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
    Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
    J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
    Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA
    Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function.
    Jacobson SH; Lu Y; Brauner A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2209-14. PubMed ID: 8941580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
    Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis.
    Müller K; Herner EB; Stagg A; Bendtzen K; Woo P
    Br J Rheumatol; 1998 May; 37(5):562-9. PubMed ID: 9651086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.
    Bleeker MW; Netea MG; Kullberg BJ; Van der Ven-Jongekrijg J; Van der Meer JW
    Immunology; 1997 Aug; 91(4):548-52. PubMed ID: 9378493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood.
    Rogers A; Eastell R
    Bone; 2001 Jul; 29(1):30-4. PubMed ID: 11472888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Vannier E; van Dalen R; Pesman G; Bartelink AK; Dinarello CA; van der Meer JW
    Blood; 1997 Aug; 90(3):1101-8. PubMed ID: 9242541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.